QWM
SNOA icon

Quaker Wealth Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Quaker Wealth Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
3
– – ﹤0.01% 968
2026
Q1 		$7 Hold
3
– – ﹤0.01% 971
2025
Q4 		$11 Hold
3
– – ﹤0.01% 964
2025
Q3 		$12 Hold
3
– – ﹤0.01% 838
2025
Q2 		$9 Buy
+3
New +$9 ﹤0.01% 865

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Quaker Wealth Management's SNOA Position: Q2 2026 in Review

Quaker Wealth Management held its Sonoma Pharmaceuticals (SNOA) position steady in Q2 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Quaker Wealth Management first reported a position in SNOA in Q2 2025 and has held it in 5 quarters since. The position peaked at $12 in Q3 2025. 12 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

  • Quaker Wealth Management held 3 shares of Sonoma Pharmaceuticals worth $4 as of Q2 2026.
  • Quaker Wealth Management left its Sonoma Pharmaceuticals share count unchanged in Q2 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #968 holding.
  • Quaker Wealth Management first reported a position in Sonoma Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Sonoma Pharmaceuticals position peaked at $12 in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.